8-K: Horizon Tech Finance Addresses Merger Lawsuits, Boosts Disclosure

Horizon Technology Finance Corporation filed an 8-K to provide supplemental disclosures regarding its proposed merger with Monroe Capital Corporation, following class action complaints alleging misleading information.

Summary

• Horizon Technology Finance Corporation (HRZN) entered into an Agreement and Plan of Merger with Monroe Capital Corporation (MRCC) on August 7, 2025.
• The merger involves an Asset Sale by MRCC to Monroe Capital Income Plus Corporation (MCIP), followed by two mergers: Merger Sub into MRCC, then MRCC into HRZN.
• Multiple putative class action complaints were filed starting January 30, 2026, in Delaware and New York, alleging materially misleading and incomplete disclosures in the Joint Proxy Statement filed on January 20, 2026.
• HRZN and its Board believe the claims are without merit but are voluntarily providing supplemental disclosures to reduce litigation costs, risks, and uncertainties.
• The HRZN Board, on the recommendation of a Special Committee of independent directors, unanimously recommends stockholders vote for the Merger Stock Issuance Proposal and the Director Election Proposal.
• Supplemental disclosures include unaudited forecasted financial information for MRCC (standalone), HRZN (standalone), and the combined company (pro forma) for years 2026-2030.
• The disclosures also clarify Oppenheimer's past and potential future financial advisory services to HRZN and MRCC.
• The supplemental disclosures will not affect the merger consideration or the timing of the Special Meeting of HRZN stockholders, scheduled for March 13, 2026, at 2:30 p.m. Eastern Time.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral-to-slightly-negative development. While the company is proactively addressing litigation with supplemental disclosures and the board unanimously supports the merger, the existence of multiple class action lawsuits introduces significant uncertainty and potential costs.

Positives

• HRZN is voluntarily providing supplemental disclosures to reduce litigation costs and risks, without admitting any liability or wrongdoing.
• The HRZN Board, based on the recommendation of a Special Committee of independent directors, unanimously recommends voting for the Merger Stock Issuance Proposal and the Director Election Proposal.
• The supplemental disclosures do not affect the merger consideration or the timing of the Special Meeting, indicating the merger process remains on schedule.
• Pro forma projections for the combined company show an increase in estimated Net Investment Income Per Share from $1.02 in 2027 to $1.24 in 2030, and an increase in Estimated Net Asset Value Per Share from $6.55 in 2026 to $7.89 in 2030.

Negatives

• Multiple class action complaints have been filed against HRZN and its Board, alleging materially misleading and incomplete disclosures in the Joint Proxy Statement related to the merger.
• The complaints seek supplemental disclosures and to enjoin the closing of the Merger, introducing legal and operational uncertainty.
• Litigation inherently brings costs, risks, and potential liabilities, even if the company believes the claims are without merit.
• Standalone MRCC projections show a decrease in Estimated Net Investment Income Per Share from $0.31 in 2026 to $0.26 in 2027, before recovering.

Risks

• Uncertainties associated with the timing or likelihood of the proposed transactions closing.
• The ability to realize the anticipated benefits, synergies, and savings associated with the proposed transactions.
• The possibility that one or more of the various closing conditions to the transactions may not be satisfied or waived, including governmental approvals or shareholder approvals.
• The risk that a governmental entity may prohibit, delay, or refuse approval for the consummation of the proposed transactions, or may require conditions, limitations, or restrictions.
• The possibility that competing offers or acquisition proposals will be made.
• Risks related to diverting management's attention from ongoing business operations.
• Uncertainties regarding the combined company's future operating results, net investment income, net asset value, or distribution projections.
• The ability of HRZN Advisor to implement its future plans with respect to the combined company.
• The expected financings, investments, and additional leverage that the combined company may seek to incur in the future.
• The adequacy of the cash resources and working capital of the combined company.
• The risk that shareholder litigation in connection with the proposed transactions may result in significant costs of defense and liability.
• Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates.
• Risks associated with possible disruption in operations or the economy generally due to terrorism, war, natural disasters, tariffs, or public health crises and epidemics.
• Future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities).
• Conditions in MRCC's and HRZN's operating areas, particularly with respect to business development companies or regulated investment companies.
• There is no assurance that the market price of HRZN's shares, either absolutely or relative to net asset value, will increase as a result of any share repurchases, or that any repurchase plan will enhance shareholder value over the long term.

Future Outlook

The proposed merger is expected to lead to improved operations, enhanced revenues and cash flow, growth potential, market profile, and financial strength for the combined entity. However, these are forward-looking statements subject to risks and uncertainties, including the timing and likelihood of closing, the ability to realize synergies, governmental and shareholder approvals, and potential litigation costs. The pro forma projections indicate a positive trend in Net Investment Income and Net Asset Value per share for the combined company post-2027, with estimated Net Investment Income Per Share growing from $1.02 in 2027 to $1.24 in 2030, and Estimated Net Asset Value Per Share increasing from $6.55 in 2026 to $7.89 in 2030.

Management Comments

• On the recommendation of a Special Committee of the HRZN Board, comprised of the independent directors of the HRZN Board, the HRZN Board has unanimously recommended that HRZN stockholders vote for the Merger Stock Issuance Proposal.
• In addition, the HRZN Board, including all of its independent directors, has unanimously recommended that HRZN stockholders vote for the Director Election Proposal.
• HRZN and the individual defendants believe that HRZN has previously disclosed all information required to be disclosed to ensure that its stockholders can make an informed vote at the Special Meeting and that the additional disclosures requested by the plaintiffs are not required under applicable law.
• HRZN and the individual defendants believe the claims asserted in the Merger Complaints are without merit.

Industry Context

StockSavvy.ai notes that the Business Development Company (BDC) sector frequently sees consolidation as companies seek scale, operational efficiencies, and broader investment portfolios. This merger, despite the legal challenges, aligns with a trend of BDCs aiming to enhance shareholder value through strategic combinations. The litigation highlights the intense scrutiny on disclosure practices in complex financial transactions within the highly regulated BDC environment.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry benchmarks or comparable companies' projects and results.
• The projected dividend per share for the combined entity remaining flat at $1.00 from 2026-2030, while Net Investment Income per share is projected to grow, suggests a conservative dividend policy or reinvestment strategy, which can be common among BDCs focused on long-term Net Asset Value growth.
• The pro forma Net Asset Value per share growth from $6.55 in 2026 to $7.89 in 2030 (approximately 4.7% CAGR) indicates a healthy projected increase in shareholder equity, which is a key metric for BDC performance.

Corporate Governance

Legal Proceedings

• A putative class action complaint was filed on January 30, 2026, in the Court of Chancery of the State of Delaware against HRZN and certain members of its Board of Directors.
• Two additional complaints with substantially similar allegations were filed in the Supreme Court of the State of New York against HRZN and the HRZN Board.
• The Merger Complaints allege, among other things, that the combined definitive joint proxy statement for HRZN and MRCC and prospectus of HRZN filed on January 20, 2026, contains materially misleading and incomplete disclosures.
• The Merger Complaints seek, among other things, that HRZN make supplemental disclosures to address the alleged materially misleading and incomplete disclosures and to enjoin the closing of the Merger.

Related Party Transactions

• Oppenheimer, financial advisor to the HRZN Special Committee, has in the past provided and may in the future provide financial advisory and/or other services to HRZN, MRCC, their affiliates, or other participants in the Merger.
• In the past two years, Oppenheimer has not provided investment banking, financial advisory, and/or other financial or consulting services to HRZN or MRCC, or to any portfolio companies that either HRZN or MRCC would be deemed to control, for which Oppenheimer has received compensation.

Stakeholder Impact

• Shareholders (HRZN & MRCC): Will vote on the merger. The supplemental disclosures aim to provide more information for an informed vote. Litigation introduces uncertainty and potential delays/costs. The pro forma projections suggest potential long-term value creation.
• Management/Employees: The merger will lead to a combined entity, potentially impacting roles and organizational structure.
• Creditors: The mention of "additional leverage" as a forward-looking risk could impact the credit profile of the combined entity.

Next Steps

• HRZN stockholders to vote on the Merger Stock Issuance Proposal and Director Election Proposal at the Special Meeting on March 13, 2026.
• Consummation of the Asset Sale by MRCC to MCIP.
• Completion of the Initial Merger (Merger Sub into MRCC).
• Completion of the Second Merger (MRCC into HRZN).

Key Dates

Recommendation

The filing presents a mixed bag. While the board unanimously recommends the merger and the pro forma projections show potential long-term value, the ongoing class action lawsuits introduce significant legal and financial uncertainty. Investors should hold to monitor the outcome of the litigation and the successful completion of the merger, as these factors will heavily influence the stock's near-term performance.

Keywords

Merger, Acquisition, SEC Filing, 8-K, Horizon Technology Finance, Monroe Capital, Litigation, Class Action, Proxy Statement, Financial Projections, Corporate Governance, Investment Income, Net Asset Value, Dividends, BDC